Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New prostacyclins from Asahi Glass

Sep. 20, 1996

Anticoagulant for treating blood clots approved in Canada

Sep. 20, 1996

R&D in blood coauglation at Daiichi

Sep. 13, 1996

Review on gpIIb/IIIa antagonists for ischemic complications

Sep. 13, 1996

Antiplatelet agents reported by Lilly

Sep. 13, 1996

Promising phase I data reported for oral heparin

Sep. 13, 1996

First human trial for transgenic product

Sep. 13, 1996

Genetics Institute's recombinant factor IX submitted for approval

Sep. 6, 1996

Monoclonal antibody for thrombotic disorders from Teijin

Sep. 6, 1996

Roche and Genentech prepare prodrugs of fibrinogen antagonist

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...